Logo image of VNTR

VENATOR MATERIALS PLC (VNTR) Stock Fundamental Analysis

NYSE:VNTR - New York Stock Exchange, Inc. - GB00BF3ZNS54 - Common Stock - Currency: USD

0.2687  -0.02 (-7.66%)

After market: 0.2783 +0.01 (+3.57%)

Fundamental Rating

1

VNTR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. VNTR has a bad profitability rating. Also its financial health evaluation is rather negative. VNTR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year VNTR has reported negative net income.
In the past year VNTR has reported a negative cash flow from operations.
In the past 5 years VNTR always reported negative net income.
Of the past 5 years VNTR 4 years had a positive operating cash flow.
VNTR Yearly Net Income VS EBIT VS OCF VS FCFVNTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M -200M 400M

1.2 Ratios

The profitability ratios for VNTR are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VNTR Yearly ROA, ROE, ROICVNTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60

1.3 Margins

The Gross Margin of VNTR (3.91%) is worse than 86.81% of its industry peers.
VNTR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for VNTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.52%
GM growth 5Y-29.5%
VNTR Yearly Profit, Operating, Gross MarginsVNTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

VNTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VNTR has been increased compared to 1 year ago.
VNTR has a worse debt/assets ratio than last year.
VNTR Yearly Shares OutstandingVNTR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
VNTR Yearly Total Debt VS Total AssetsVNTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.38, we must say that VNTR is in the distress zone and has some risk of bankruptcy.
VNTR has a Altman-Z score of 0.38. This is in the lower half of the industry: VNTR underperforms 76.92% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that VNTR is not too dependend on debt financing.
VNTR's Debt to Equity ratio of 0.02 is amongst the best of the industry. VNTR outperforms 83.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC5.34%
VNTR Yearly LT Debt VS Equity VS FCFVNTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

VNTR has a Current Ratio of 0.74. This is a bad value and indicates that VNTR is not financially healthy enough and could expect problems in meeting its short term obligations.
VNTR's Current ratio of 0.74 is on the low side compared to the rest of the industry. VNTR is outperformed by 90.11% of its industry peers.
A Quick Ratio of 0.41 indicates that VNTR may have some problems paying its short term obligations.
VNTR has a worse Quick ratio (0.41) than 91.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.41
VNTR Yearly Current Assets VS Current LiabilitesVNTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for VNTR have decreased strongly by -3300.00% in the last year.
Looking at the last year, VNTR shows a decrease in Revenue. The Revenue has decreased by -1.76% in the last year.
The Revenue has been decreasing by -0.33% on average over the past years.
EPS 1Y (TTM)-3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y0.67%
Revenue growth 5Y-0.33%
Sales Q2Q%-31.59%

3.2 Future

VNTR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.60% yearly.
The Revenue is expected to decrease by -2.01% on average over the next years.
EPS Next Y-403.14%
EPS Next 2Y-41.02%
EPS Next 3Y-2.6%
EPS Next 5YN/A
Revenue Next Year-17.52%
Revenue Next 2Y-5.89%
Revenue Next 3Y-2.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VNTR Yearly Revenue VS EstimatesVNTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
VNTR Yearly EPS VS EstimatesVNTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VNTR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VNTR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VNTR Price Earnings VS Forward Price EarningsVNTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VNTR indicates a somewhat cheap valuation: VNTR is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.62
VNTR Per share dataVNTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as VNTR's earnings are expected to decrease with -2.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.02%
EPS Next 3Y-2.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VNTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENATOR MATERIALS PLC

NYSE:VNTR (5/12/2023, 8:06:13 PM)

After market: 0.2783 +0.01 (+3.57%)

0.2687

-0.02 (-7.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-03 2023-05-03/amc
Earnings (Next)N/A N/A
Inst Owners0.54%
Inst Owner Change0%
Ins Owners39.98%
Ins Owner Change0%
Market Cap29.03M
Analysts48.33
Price Target0.47 (74.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-895.11%
Min EPS beat(2)-1848.97%
Max EPS beat(2)58.75%
EPS beat(4)3
Avg EPS beat(4)-431.83%
Min EPS beat(4)-1848.97%
Max EPS beat(4)58.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.89%
Min Revenue beat(2)-12.31%
Max Revenue beat(2)-3.46%
Revenue beat(4)1
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-12.31%
Max Revenue beat(4)3.6%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.19%
PT rev (3m)-57.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-106.49%
EPS NY rev (1m)-13.32%
EPS NY rev (3m)-220.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-8.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.1
EV/EBITDA 9.62
EPS(TTM)-0.34
EYN/A
EPS(NY)-1.71
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS20.11
BVpS2.83
TBVpS2.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.91%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.52%
GM growth 5Y-29.5%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 10.47
Cap/Depr 64.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.41
Altman-Z 0.38
F-Score3
WACC5.34%
ROIC/WACCN/A
Cap/Depr(3y)62.12%
Cap/Depr(5y)114.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-403.14%
EPS Next 2Y-41.02%
EPS Next 3Y-2.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y0.67%
Revenue growth 5Y-0.33%
Sales Q2Q%-31.59%
Revenue Next Year-17.52%
Revenue Next 2Y-5.89%
Revenue Next 3Y-2.01%
Revenue Next 5YN/A
EBIT growth 1Y-170%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-269.56%
EBIT Next 3Y102.19%
EBIT Next 5YN/A
FCF growth 1Y-238.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-700%
OCF growth 3YN/A
OCF growth 5YN/A